Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Argan (AGX) EBT (2016 - 2025)

Argan's EBT history spans 16 years, with the latest figure at $39.7 million for Q4 2025.

  • For Q4 2025, EBT rose 7.34% year-over-year to $39.7 million; the TTM value through Oct 2025 reached $143.7 million, up 60.52%, while the annual FY2025 figure was $111.2 million, 127.26% up from the prior year.
  • EBT for Q4 2025 was $39.7 million at Argan, up from $35.6 million in the prior quarter.
  • Across five years, EBT topped out at $39.7 million in Q4 2025 and bottomed at -$195000.0 in Q1 2022.
  • The 5-year median for EBT is $15.1 million (2021), against an average of $18.5 million.
  • The largest annual shift saw EBT crashed 101.62% in 2022 before it surged 6266.67% in 2023.
  • A 5-year view of EBT shows it stood at $15.7 million in 2021, then plummeted by 34.18% to $10.3 million in 2022, then rose by 12.46% to $11.6 million in 2023, then soared by 218.97% to $37.0 million in 2024, then rose by 7.34% to $39.7 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's EBT are $39.7 million (Q4 2025), $35.6 million (Q3 2025), and $29.8 million (Q2 2025).